Video Experimental Relacionado

Updated: Mar 1, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Declive de la función visual y riesgo de ceguera legal con la edad en la degeneración retiniana asociada a RPGR: un

Bela J Parekh^1,2, Joshua D Stein^1,3, Rebhi Abuzaitoun¹

¹W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA.

Clinical & experimental ophthalmology

|February 27, 2026

Abstracto

Background:

This retrospective multicenter longitudinal analysis analysed the loss trajectory of best recorded visual acuity (BRVA) and Goldmann visual field (GVF) in RPGR-associated retinal degeneration (RPGR-RD).

Methods:

Patients with genetically confirmed RPGR-RD were classified into rod-cone (RC), cone/cone-rod (CR) and female-carrier phenotypes. BRVAs and GVFs for both eyes were captured at each clinical encounter. Scatterplots of BRVA versus age and GVF versus age were overlaid with local polynomial smoothers to show the loss trajectory.

Results:

Two hundred eighty-one patients were identified, including 220 males (158 RC, 44 CR, 18 uncategorized) and 61 female carriers. For the RC group, mean ± SD (range) age of first contact in SOURCE was 24.8 ± 17.2 years (0-69), duration of follow-up was 6.0 ± 5.2 years and at some point during the study, 36/142 (25%) had legal blindness by BRVA and 57/108 (53%) by GVF. Median age of first record of blindness by GVF was 31 years (95% CI, 27-35 years) and by BRVA was 47 years (95% CI, 43-52 years); GVF steeply declined after age 20. For the CR group, mean age of first entry in SOURCE was 32.4 ± 18.8 years (1-66), duration of follow-up was 4.8 ± 3.6 years and 9/42 (21%) had legal blindness by BRVA at ≥ 1 visit. The median age of first record of blindness by BRVA was 60 years (95% CI, 51-73 years).

Conclusions:

All phenotypic groups of RPGR-RD experienced longitudinal loss of BRVA and GVF. Rapid decline in GVF for the RC phenotype suggests that intervention may be most effective prior to this window.

Palabras clave:

enfermedades oculares, hereditarias distrofias de conos-bastones degeneración retiniana retinitis pigmentosa retinitis pigmentosa

Más Videos Relacionados

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

Videos de Conceptos Relacionados

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...

Anatomy of the Eyeball

Anatomy of the Eyeball

The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...